DK1090915T3 - Polymorphic B form af 3-(cyclopropylmethoxy)-4--4-(methylsulfonyl)phenyl- 5,5-dimethyl-5H-furan-2-on - Google Patents
Polymorphic B form af 3-(cyclopropylmethoxy)-4--4-(methylsulfonyl)phenyl- 5,5-dimethyl-5H-furan-2-onInfo
- Publication number
- DK1090915T3 DK1090915T3 DK99402482T DK99402482T DK1090915T3 DK 1090915 T3 DK1090915 T3 DK 1090915T3 DK 99402482 T DK99402482 T DK 99402482T DK 99402482 T DK99402482 T DK 99402482T DK 1090915 T3 DK1090915 T3 DK 1090915T3
- Authority
- DK
- Denmark
- Prior art keywords
- cyclopropylmethoxy
- methylsulfonyl
- polymorphic
- dimethyl
- furan
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/60—Two oxygen atoms, e.g. succinic anhydride
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99402482A EP1090915B1 (en) | 1999-10-08 | 1999-10-08 | Polymorphic B form of 3-(cyclopropylmethoxy)-4-¬-4-(methylsulfonyl)phenyl - 5,5-dimethyl-5H-furan-2-one |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1090915T3 true DK1090915T3 (da) | 2009-07-13 |
Family
ID=8242136
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99402482T DK1090915T3 (da) | 1999-10-08 | 1999-10-08 | Polymorphic B form af 3-(cyclopropylmethoxy)-4--4-(methylsulfonyl)phenyl- 5,5-dimethyl-5H-furan-2-on |
Country Status (12)
Country | Link |
---|---|
US (1) | US6677373B2 (ja) |
EP (1) | EP1090915B1 (ja) |
JP (1) | JP4805505B2 (ja) |
AT (1) | ATE432269T1 (ja) |
AU (2) | AU774172C (ja) |
CA (1) | CA2386549C (ja) |
CY (1) | CY1110062T1 (ja) |
DE (1) | DE69940922D1 (ja) |
DK (1) | DK1090915T3 (ja) |
ES (1) | ES2326849T3 (ja) |
PT (1) | PT1090915E (ja) |
WO (1) | WO2001027097A1 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2545886A1 (en) | 2003-11-13 | 2005-06-02 | University Of Georgia Research Foundation, Inc. | Methods of characterizing infectious bursal disease virus |
US7151158B2 (en) * | 2004-01-30 | 2006-12-19 | General Electric Company | Method of preparing a poly(arylene ether), apparatus therefor, and poly(arylene ether) prepared thereby |
US7862821B2 (en) | 2006-06-01 | 2011-01-04 | Merial Limited | Recombinant vaccine against bluetongue virus |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5474995A (en) * | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
UA57002C2 (uk) * | 1995-10-13 | 2003-06-16 | Мерк Фросст Кенада Енд Ко./Мерк Фросст Кенада Енд Сі. | Похідне (метилсульфоніл)феніл-2-(5н)-фуранону, фармацевтична композиція та спосіб лікування |
ATE212343T1 (de) * | 1995-10-30 | 2002-02-15 | Merck Frosst Canada Inc | 3,4-diaryl-2-hydroxy-2,5-dihydrofurane als wirkstoffvorstufen von cox-2 inhibitoren |
AU710675B2 (en) * | 1996-02-01 | 1999-09-30 | Merck Frosst Canada Ltd. | Alkylated styrenes as prodrugs to COX-2 inhibitors |
ATE244232T1 (de) * | 1997-03-14 | 2003-07-15 | Merck Frosst Canada Inc | (methylsulfonyl)phenyl-2-(5h)-furanone mit sauerstoff-bindung als cox-2-hemmer |
-
1999
- 1999-10-08 ES ES99402482T patent/ES2326849T3/es not_active Expired - Lifetime
- 1999-10-08 PT PT99402482T patent/PT1090915E/pt unknown
- 1999-10-08 AT AT99402482T patent/ATE432269T1/de active
- 1999-10-08 DE DE69940922T patent/DE69940922D1/de not_active Expired - Lifetime
- 1999-10-08 EP EP99402482A patent/EP1090915B1/en not_active Expired - Lifetime
- 1999-10-08 DK DK99402482T patent/DK1090915T3/da active
-
2000
- 2000-10-09 AU AU79218/00A patent/AU774172C/en not_active Expired
- 2000-10-09 JP JP2001530316A patent/JP4805505B2/ja not_active Expired - Lifetime
- 2000-10-09 WO PCT/EP2000/010421 patent/WO2001027097A1/en active Search and Examination
- 2000-10-09 CA CA2386549A patent/CA2386549C/en not_active Expired - Lifetime
-
2002
- 2002-04-08 US US10/117,854 patent/US6677373B2/en not_active Expired - Lifetime
-
2004
- 2004-08-31 AU AU2004206979A patent/AU2004206979A1/en not_active Abandoned
-
2009
- 2009-08-24 CY CY20091100891T patent/CY1110062T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
JP4805505B2 (ja) | 2011-11-02 |
AU774172C (en) | 2005-06-09 |
US20030050337A1 (en) | 2003-03-13 |
ES2326849T3 (es) | 2009-10-20 |
DE69940922D1 (de) | 2009-07-09 |
AU774172B2 (en) | 2004-06-17 |
AU7921800A (en) | 2001-04-23 |
CA2386549C (en) | 2010-09-21 |
EP1090915A1 (en) | 2001-04-11 |
CY1110062T1 (el) | 2015-01-14 |
CA2386549A1 (en) | 2001-04-19 |
JP2003511443A (ja) | 2003-03-25 |
AU2004206979A1 (en) | 2004-09-30 |
US6677373B2 (en) | 2004-01-13 |
WO2001027097A1 (en) | 2001-04-19 |
EP1090915B1 (en) | 2009-05-27 |
ATE432269T1 (de) | 2009-06-15 |
PT1090915E (pt) | 2009-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA27349A1 (fr) | Composition cristalline renfermant de l'escitalopram. | |
DE69803907D1 (de) | Fungizide 2-Methoxybenzophenone | |
NO920767D0 (no) | Pyranylcyanoguanidin-derivater | |
IL98378A0 (en) | Substituted phthalides and heterocyclic phthalides,their preparation and their use as herbicides | |
HK1054911A1 (en) | Methods of synthesizing an oxidant and applications thereof | |
RS50071B (sr) | Novi oblik soli pantoprazola | |
IL143868A0 (en) | Use of 3-(2,4,6-trimethylphenyl)-4-neopentylcarbonyloxy-5,5-tetramethylene -delta 3-dihydrofurane-2-on for controlling the white fly | |
CY1107913T1 (el) | Πολυμορφικες και αλλες κρυσταλλικες μορφες cis-ftc | |
ATE237612T1 (de) | Benzofuranderivate | |
ATE288900T1 (de) | Substituierte benzoylcyclohexandione | |
DK0661291T3 (da) | Fastfasesyntese af oligoribonucleotider | |
HRP20030853B1 (en) | Crystalline form of omeprazole | |
KR950017992A (ko) | 알프조신 염산염의 2수화물 | |
CY1110062T1 (el) | Πολυμορφικη μορφη β της 3-(κυκλοπροπυλμεθοξυ)4- [ -4-(μεθυλσουλφονυλ)φαινυλ]-5,5-διμεθυλ-5η-φουραν-2-ονης | |
BR0102430A (pt) | Precursores de fragrância | |
DE60006825D1 (de) | Serotonerge benzofurane | |
ATE250021T1 (de) | Hydroxycyclopentanone | |
DK1240163T3 (da) | 3-(4,5-Dihydroisoxazol-5-yl)-benzoylpyrazoler | |
ATE282726T1 (de) | Herstellung von verbindungen auf basis von cu-in- se phasengleichgewichten | |
BR0113978A (pt) | Derivados de tiazol de 2-metoxiimino-2-(piridiniloximetil)-fenil-acetamidas úteis como fungicidas | |
ATE92479T1 (de) | Neue 1,3-oxazine. | |
AR026699A1 (es) | 3-(4,5-dihidroisoxazol-3-il)-benzoilciclohexenonas sustituidas por halogenoalquilo | |
CY1110529T1 (el) | Παρασκευη ν-υποκατεστημενων 2,7-διαλκυλο-4-υδροξυ-5-αμινο-8-αρυλοοκτανοϋλαμιδιων | |
MA24447A1 (fr) | Pour une variete de rosier intermediaire a fleurs doubles rose clair. variete "febesa" | |
JPS53147545A (en) | Electrographic stencil paper |